[Macular complications of chronic posterior cyclitis[].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002833:Choroiditis / Q000150:complications* / Q000209:etiology; D002908:Chronic Disease; D003452:Cryosurgery; D003560:Cysts / Q000209:etiology; D004487:Edema / Q000188:drug therapy / Q000209:etiology*; D005122:Exudates and Transudates; D005451:Fluorescein Angiography; D005654:Fundus Oculi; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007500:Iritis / Q000150:complications* / Q000209:etiology; D008266:Macula Lutea; D011379:Prognosis; D012162:Retinal Degeneration / Q000209:etiology; D012164:Retinal Diseases / Q000209:etiology; D014605:Uveitis / Q000150:complications*; D014792:Visual Acuity; D014822:Vitreous Body
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents
Les complications maculaires des "cyclites chroniques postérieures"